All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Bob Ragusa, the most common co-covered peer. The tracked stories average 2 original sources each. Galleri appears in 1 tracked Healthcare story from March 22, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Galleri
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Bob Ragusa, the most common co-covered peer. The tracked stories average 2 original sources each. Galleri appears in 1 tracked Healthcare story from March 22, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Galleri. Shared-story counts are live from our verified record — not editorial picks.
Grail (GRAL) stock staged a major recovery this week, outperforming the broader market after a pivotal upgrade from TD Cowen. The rally marks a significant shift in investor sentiment following a volatile period triggered by a CEO transition and clinical trial concerns.